MarketResearchReports.Biz

Impact of the Bio CMO Market Analysis, Size, Trends & Forecasts (2016-2021)

The Report Global Bio CMO Market: Size, Trends & Forecasts (2016-2021) provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz

 

Albany, NY -- (SBWIRE) -- 03/09/2017 -- Scope of the Report

The report entitled Global Bio CMO Market: Size, Trends & Forecasts (2016-2021), provides analysis of the global bio CMO market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the global biologics market by value, by top selling products, etc.

Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global bio CMO market has been forecasted for the years 2016-2021, taking into consideration the previous growth pattern, the growth drivers and the current and future trends.

Lonza, Boehringer Ingelheim, Samsung Biologics are key companies in the global bio CMO market. The company profiling of these companies has been done in the report, which includes business overview, financial overview and respective business strategies of the companies.

View Report @ http://www.marketresearchreports.biz/analysis/948217

Company Coverage

Lonza
Boehringer Ingelheim
Samsung Electronics (Samsung Biologics)

Executive Summary

Pharmaceutical industry comprise of discovering, developing, producing and marketing of drugs for medical use. Worlds largest pharmaceutical firms are located in the North America, Europe and Japan. On the basis of technological platform, pharmaceutical drugs can be divided into small molecule or conventional drugs and large molecule or biologic drugs.

Biologics are made through biological processes and are generally injected. Biologics comprises of vaccines, blood or blood components, somatic cells, gene therapy, etc. Biologics are categorized into first-or second generation, depending on development period and cell line. Biosimilars are the biological that are similar, but not identical to the original product.

Get Sample Copy Of This Report @ http://www.marketresearchreports.biz/sample/sample/948217

CMO or Contract Manufacturing Organization is a third party, which the pharmaceutical firms approach for the manufacturing of components of its product or whole of its product. Bio CMOs are typically used to provide secondary manufacturing coverage for the branded pharmaceutical industry. On the basis of production technology, bio CMOs can be divided into mammalian cell system and microbial system.

The global bio CMO market is expected to increase at a significant growth rate during the forecasted period (2016-2021). The global bio CMO market is supported by various growth drivers, such as increase in pharmaceutical industry, growth in use of biosimilars, potential biologics blockbusters, etc. Yet, the market faces certain challenges, such as risk associated with CMOs, presence of in-house manufacturing facilities of big pharma companies, productivity issues with mammalian cell system, etc.

Table Of Contents :

1. Executive Summary

2. Introduction

2.1 Pharmaceutical Industry Overview
2.1.1 Segments of Pharmaceutical Industry (Drugs)
2.2 Biotechnology/Biologics Overview
2.3 Biosimilar Overview
2.4 Biologics/ Biosimilar Manufacturing
2.5 Bio CMO Overview

3. Global Market Analysis

3.1 Global Biologics Market: An Analysis
3.1.1 Global Biologics Market by Value
3.1.2 Global Biologics Market by Top Selling Drugs
3.1.3 Global Biologics Market by Product in Development
3.1.4 Global Biologics Manufacturing market by Value

3.2 Global Bio CMO Market: An Analysis
3.2.1 Global Bio CMO Market by Penetration Rate
3.2.2 Global Bio CMO Market by Value
3.2.3 Global Bio CMO Market by Capacity
3.2.4 Global Bio CMO Market by Segments

4. Market Dynamics

4.1 Growth Drivers
4.1.1 Global Pharmaceutical Market Growth
4.1.2 Potential Biologics Blockbusters
4.1.3 Increase in Biosimilar Market
4.1.4 Preference of Biologics Over Small Molecules

4.2 Challenges
4.2.1 Presence for In-House Biopharma Manufacturing
4.2.2 Risk Associated with CMOs
4.2.3 Productivity Issue with Mammalian Cell System

4.3 Market Trends
4.3.1 Big Pharmaceuticals Outsourcing Rate
4.3.2 Capacity Utilization Rate of CMOs
4.3.3 Growth in Mammalian Cell Structure
4.3.4 Stringent Regulatory Requirements for Biologics and Biosimilars

5. Competitive Landscape

5.1 Global Bio CMO Market by Number of Firms
5.2 Global Bio CMO Market Players by Capacity

About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
Mr. Nachiket
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: 518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz